Evaluating Frequency, Diagnostic Quality, and Cost of Lyme Borreliosis Testing in Germany : A Retrospective Model Analysis

Background. Data on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs for laboratory testing in LB patients in Germany. Materials and Methods. We performed a sentinel analysis of epidemiological and medicoeconom...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clinical & developmental immunology Ročník 2012; číslo 2012; s. 1 - 13
Hlavní autoři: Freitag, M. H., Müller, I., Poggensee, G., Scharnetzky, E., Straube, E., Schoerner, Ch, Hlobil, H., Hagedorn, H.-J., Stanek, Gerold, Schubert-Unkmeir, A., Norris, D. E., Gensichen, J., Hunfeld, Klaus P.
Médium: Journal Article
Jazyk:angličtina
Vydáno: Cairo, Egypt Hindawi Puplishing Corporation 01.01.2012
Hindawi Publishing Corporation
Wiley
Témata:
Borrelia - immunology
Clinical Laboratory Techniques - economics
Clinical Laboratory Techniques - standards
Germany - epidemiology
Health Care Costs
Humans
Incidence
Insurance, Health - economics
Lyme Disease - diagnosis
Lyme Disease - economics
Lyme Disease - epidemiology
Models, Statistical
Outpatients
Prevalence
Reagent Kits, Diagnostic - standards
Reproducibility of Results
Retrospective Studies
Sensitivity and Specificity
Germany
ISSN:1740-2522, 1740-2530, 1740-2530
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background. Data on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs for laboratory testing in LB patients in Germany. Materials and Methods. We performed a sentinel analysis of epidemiological and medicoeconomic data for 2007 and 2008. Data was provided by a German statutory health insurance (DAK) company covering approx. 6.04 million members. In addition, the quality of diagnostic testing for LB in Germany was studied. Results. In 2007 and 2008, the incident diagnosis LB was coded on average for 15,742 out of 6.04 million insured members (0.26%). 20,986 EIAs and 12,558 immunoblots were ordered annually for these patients. For all insured members in the outpatient sector, a total of 174,820 EIAs and 52,280 immunoblots were reimbursed annually to health care providers (cost: 2,600,850€). For Germany, the overall expected cost is estimated at 51,215,105€. However, proficiency testing data questioned test quality and standardization of diagnostic assays used. Conclusion. Findings from this study suggest ongoing issues related to care for LB and may help to improve future LB disease management.
AbstractList Data on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs for laboratory testing in LB patients in Germany.BACKGROUNDData on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs for laboratory testing in LB patients in Germany.We performed a sentinel analysis of epidemiological and medicoeconomic data for 2007 and 2008. Data was provided by a German statutory health insurance (DAK) company covering approx. 6.04 million members. In addition, the quality of diagnostic testing for LB in Germany was studied.MATERIALS AND METHODSWe performed a sentinel analysis of epidemiological and medicoeconomic data for 2007 and 2008. Data was provided by a German statutory health insurance (DAK) company covering approx. 6.04 million members. In addition, the quality of diagnostic testing for LB in Germany was studied.In 2007 and 2008, the incident diagnosis LB was coded on average for 15,742 out of 6.04 million insured members (0.26%). 20,986 EIAs and 12,558 immunoblots were ordered annually for these patients. For all insured members in the outpatient sector, a total of 174,820 EIAs and 52,280 immunoblots were reimbursed annually to health care providers (cost: 2,600,850€). For Germany, the overall expected cost is estimated at 51,215,105€. However, proficiency testing data questioned test quality and standardization of diagnostic assays used.RESULTSIn 2007 and 2008, the incident diagnosis LB was coded on average for 15,742 out of 6.04 million insured members (0.26%). 20,986 EIAs and 12,558 immunoblots were ordered annually for these patients. For all insured members in the outpatient sector, a total of 174,820 EIAs and 52,280 immunoblots were reimbursed annually to health care providers (cost: 2,600,850€). For Germany, the overall expected cost is estimated at 51,215,105€. However, proficiency testing data questioned test quality and standardization of diagnostic assays used.Findings from this study suggest ongoing issues related to care for LB and may help to improve future LB disease management.CONCLUSIONFindings from this study suggest ongoing issues related to care for LB and may help to improve future LB disease management.
Background. Data on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs for laboratory testing in LB patients in Germany. Materials and Methods. We performed a sentinel analysis of epidemiological and medicoeconomic data for 2007 and 2008. Data was provided by a German statutory health insurance (DAK) company covering approx. 6.04 million members. In addition, the quality of diagnostic testing for LB in Germany was studied. Results. In 2007 and 2008, the incident diagnosis LB was coded on average for 15,742 out of 6.04 million insured members (0.26%). 20,986 EIAs and 12,558 immunoblots were ordered annually for these patients. For all insured members in the outpatient sector, a total of 174,820 EIAs and 52,280 immunoblots were reimbursed annually to health care providers (cost: 2,600,850€). For Germany, the overall expected cost is estimated at 51,215,105€. However, proficiency testing data questioned test quality and standardization of diagnostic assays used. Conclusion. Findings from this study suggest ongoing issues related to care for LB and may help to improve future LB disease management.
Data on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs for laboratory testing in LB patients in Germany. We performed a sentinel analysis of epidemiological and medicoeconomic data for 2007 and 2008. Data was provided by a German statutory health insurance (DAK) company covering approx. 6.04 million members. In addition, the quality of diagnostic testing for LB in Germany was studied. In 2007 and 2008, the incident diagnosis LB was coded on average for 15,742 out of 6.04 million insured members (0.26%). 20,986 EIAs and 12,558 immunoblots were ordered annually for these patients. For all insured members in the outpatient sector, a total of 174,820 EIAs and 52,280 immunoblots were reimbursed annually to health care providers (cost: 2,600,850€). For Germany, the overall expected cost is estimated at 51,215,105€. However, proficiency testing data questioned test quality and standardization of diagnostic assays used. Findings from this study suggest ongoing issues related to care for LB and may help to improve future LB disease management.
Background . Data on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs for laboratory testing in LB patients in Germany. Materials and Methods . We performed a sentinel analysis of epidemiological and medicoeconomic data for 2007 and 2008. Data was provided by a German statutory health insurance (DAK) company covering approx. 6.04 million members. In addition, the quality of diagnostic testing for LB in Germany was studied. Results . In 2007 and 2008, the incident diagnosis LB was coded on average for 15,742 out of 6.04 million insured members (0.26%). 20,986 EIAs and 12,558 immunoblots were ordered annually for these patients. For all insured members in the outpatient sector, a total of 174,820 EIAs and 52,280 immunoblots were reimbursed annually to health care providers (cost: 2,600,850€). For Germany, the overall expected cost is estimated at 51,215,105€. However, proficiency testing data questioned test quality and standardization of diagnostic assays used. Conclusion . Findings from this study suggest ongoing issues related to care for LB and may help to improve future LB disease management.
Author Schoerner, Ch
Freitag, M. H.
Hlobil, H.
Stanek, Gerold
Hunfeld, Klaus P.
Poggensee, G.
Straube, E.
Schubert-Unkmeir, A.
Gensichen, J.
Hagedorn, H.-J.
Norris, D. E.
Scharnetzky, E.
Müller, I.
AuthorAffiliation 4 Deutsche Angestellten-Krankenkasse (DAK), Nagelsweg 27-31, 20097 Hamburg, Germany
3 Surveillance Unit, Department of Infectious Disease Epidemiology, Robert Koch-Institute, DGZ-Ring 1, 13086 Berlin, Germany
5 Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, North Wolfe Street, MD 21205, USA
2 Department of General Practice and Family Medicine, Jena University Hospital, Bachstraße 18, 07743 Jena, Germany
1 Bacteriologic Infection Serology Study Group of Germany (BISSGG), Central Laboratory, Institute for Laboratory Medicine, Northwest Medical Centre, Academic Teaching Hospital, Medical Faculty, Johann Wolfgang Goethe-University, Steinbacher Hohl 2-26, 60488 Frankfurt am Main, Germany
AuthorAffiliation_xml – name: 4 Deutsche Angestellten-Krankenkasse (DAK), Nagelsweg 27-31, 20097 Hamburg, Germany
– name: 3 Surveillance Unit, Department of Infectious Disease Epidemiology, Robert Koch-Institute, DGZ-Ring 1, 13086 Berlin, Germany
– name: 1 Bacteriologic Infection Serology Study Group of Germany (BISSGG), Central Laboratory, Institute for Laboratory Medicine, Northwest Medical Centre, Academic Teaching Hospital, Medical Faculty, Johann Wolfgang Goethe-University, Steinbacher Hohl 2-26, 60488 Frankfurt am Main, Germany
– name: 5 Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, North Wolfe Street, MD 21205, USA
– name: 2 Department of General Practice and Family Medicine, Jena University Hospital, Bachstraße 18, 07743 Jena, Germany
Author_xml – sequence: 1
  fullname: Freitag, M. H.
– sequence: 2
  fullname: Müller, I.
– sequence: 3
  fullname: Poggensee, G.
– sequence: 4
  fullname: Scharnetzky, E.
– sequence: 5
  fullname: Straube, E.
– sequence: 6
  fullname: Schoerner, Ch
– sequence: 7
  fullname: Hlobil, H.
– sequence: 8
  fullname: Hagedorn, H.-J.
– sequence: 9
  fullname: Stanek, Gerold
– sequence: 10
  fullname: Schubert-Unkmeir, A.
– sequence: 11
  fullname: Norris, D. E.
– sequence: 12
  fullname: Gensichen, J.
– sequence: 13
  fullname: Hunfeld, Klaus P.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22242037$$D View this record in MEDLINE/PubMed
BookMark eNqFkk1vEzEQhleoiH7AiTPINyQg1Pba8ZoDUhraUikIgXK3vN5x6sqxU3uTKvx6nG6JKBLi5NHMM--MZ-a4OggxQFW9JPgDIZyfUkzoKZecUfGkOiKC4RHlNT7Y25QeVsc532BcbNk8qw4ppYziWhxVP8832q9178ICXSS4XUMw2_fos9OLEHPvDPq-1t71xadDh6bFh6JFs-0S0FlMCbyL2WU0h3yv4QK6hLTUYYs-ogn6AX2KeQWmdxtAX2MHHk2C9tuS87x6arXP8OLhPanmF-fz6ZfR7Nvl1XQyGxku6n5kJOG05qYRltJWYKlZK7kRjZG4BVsboYXAdWvrrrFCjgGT8dhwybiRZgz1SXU1yHZR36hVckudtipqp-4dMS2UTuWjHpRtQOOGMJBEMmmppKbtmC2D5QY63BatT4PWat0uoTMQ-qT9I9HHkeCu1SJuVE05I5QVgTcPAimWWedeLV024L0OENdZSTImrCGUFvL1n6X2NX6vrgDvBsCUCecEdo8QrHaHoXaHoYbDKDT5izauL2uPuz6d_0fO2yHn2oVO37n_FHg1wFAQsHoPs6YWpeFfopzReg
CitedBy_id crossref_primary_10_2147_CEOR_S306391
crossref_primary_10_1016_j_ttbdis_2014_04_009
crossref_primary_10_1016_j_ttbdis_2019_101363
crossref_primary_10_1016_j_npbr_2013_10_004
crossref_primary_10_1128_aem_01555_21
crossref_primary_10_1016_j_ttbdis_2017_12_014
crossref_primary_10_1038_s41598_018_33136_0
crossref_primary_10_1089_vbz_2022_0046
crossref_primary_10_1016_j_jvs_2017_04_040
crossref_primary_10_1007_s10096_012_1759_7
crossref_primary_10_1016_j_ttbdis_2017_05_003
crossref_primary_10_1007_s00103_023_03703_6
crossref_primary_10_1007_s11298_014_1201_9
crossref_primary_10_1099_jmm_0_000009
crossref_primary_10_1007_s00436_022_07445_3
crossref_primary_10_1097_QCO_0000000000000332
crossref_primary_10_1007_s10096_019_03631_x
crossref_primary_10_1089_vbz_2015_1790
crossref_primary_10_1016_j_jvs_2018_05_248
crossref_primary_10_1099_ijsem_0_004149
crossref_primary_10_1186_s12879_022_07863_9
crossref_primary_10_1007_s00103_013_1919_7
crossref_primary_10_1155_2015_389081
crossref_primary_10_3389_fmicb_2019_01596
crossref_primary_10_1080_10408363_2018_1450353
crossref_primary_10_1371_journal_pone_0116767
crossref_primary_10_1093_eurpub_ckw269
crossref_primary_10_1128_JCM_02111_15
crossref_primary_10_1007_s00103_013_1925_9
crossref_primary_10_1111_imj_13278
crossref_primary_10_1016_j_cca_2017_06_024
crossref_primary_10_1007_s12688_023_00698_5
crossref_primary_10_1007_s10096_021_04366_4
crossref_primary_10_1007_s00772_018_0371_2
crossref_primary_10_3896_IBRA_1_51_4_01
crossref_primary_10_1089_vbz_2016_1962
crossref_primary_10_1007_s00772_018_0387_7
crossref_primary_10_1111_mve_12537
crossref_primary_10_1007_s00484_017_1362_9
crossref_primary_10_1016_j_ttbdis_2024_102326
crossref_primary_10_1016_j_ttbdis_2018_08_010
crossref_primary_10_1038_nrneurol_2015_121
crossref_primary_10_3389_frym_2022_662665
crossref_primary_10_1186_s13690_017_0202_z
crossref_primary_10_1016_j_cmi_2017_08_025
crossref_primary_10_1186_s12879_016_1468_4
crossref_primary_10_1099_mgen_0_001252
crossref_primary_10_1111_zph_13180
crossref_primary_10_1016_j_ttbdis_2013_10_010
crossref_primary_10_1007_s10493_019_00381_5
crossref_primary_10_1016_j_ttbdis_2025_102454
crossref_primary_10_1016_j_puhe_2023_03_002
crossref_primary_10_3389_fmicb_2020_00690
Cites_doi 10.1001/archinte.156.14.1493
10.1111/j.1469-0691.2010.03175.x
10.1128/CMR.8.1.1
10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y
10.1128/JCM.44.4.1335-1341.2006
10.1007/s00103-008-0703-6
10.1056/NEJM200107123450207
10.1128/JCM.40.7.2431-2436.2002
10.1016/S0033-3506(03)00067-2
10.7326/0003-4819-127-12-199712150-00011
10.1001/archinte.150.4.732
10.1016/S0934-8840(98)80125-4
10.1001/jama.282.1.62
10.3205/lab000004
10.1007/s15010-001-2005-x
10.1001/jama.279.3.206
10.1001/jama.269.14.1812
10.1001/jama.268.7.891
10.1016/0895-4356(94)00243-J
10.1370/afm.117
10.1001/jama.262.24.3431
10.1128/JCM.28.8.1774-1779.1990
10.1128/JCM.35.3.537-543.1997
10.1016/S1438-4221(02)80005-4
10.1093/infdis/155.6.1325
10.1159/000213074
10.1016/S0149-2918(98)80081-7
10.1093/ije/25.2.435
10.1001/archinte.150.4.761
10.1007/s00103-008-0654-y
10.1128/AEM.00116-09
10.1056/NEJMra072023
10.3201/eid1204.050602
10.1007/s00103-008-0644-0
ContentType Journal Article
Contributor Schubert-Unkmeir, A
Hunfeld, Klaus P
Schoerner, Ch
Straube, E
Gensichen, J
Poggensee, G
Scharnetzky, E
Stanek, Gerold
Müller, I
Hagedorn, H.-J
Norris, D. E
Freitag, M. H
Hlobil, H
Contributor_xml – sequence: 1
  fullname: Freitag, M. H
– sequence: 2
  fullname: Müller, I
– sequence: 3
  fullname: Poggensee, G
– sequence: 4
  fullname: Scharnetzky, E
– sequence: 5
  fullname: Straube, E
– sequence: 6
  fullname: Schoerner, Ch
– sequence: 7
  fullname: Hlobil, H
– sequence: 8
  fullname: Hagedorn, H.-J
– sequence: 9
  fullname: Stanek, Gerold
– sequence: 10
  fullname: Schubert-Unkmeir, A
– sequence: 11
  fullname: Norris, D. E
– sequence: 12
  fullname: Gensichen, J
– sequence: 13
  fullname: Hunfeld, Klaus P
Copyright Copyright © 2012 I. Müller et al.
Copyright © 2012 I. Müller et al. 2012
Copyright_xml – notice: Copyright © 2012 I. Müller et al.
– notice: Copyright © 2012 I. Müller et al. 2012
DBID ADJCN
AHFXO
RHU
RHW
RHX
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1155/2012/595427
DatabaseName الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals
معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete
Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

CrossRef
Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ (selected full-text)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1740-2530
Editor Lewczuk, Piotr
Editor_xml – sequence: 1
  givenname: Piotr
  surname: Lewczuk
  fullname: Lewczuk, Piotr
EndPage 13
ExternalDocumentID oai_doaj_org_article_f8ea0814e91949f292cbd4f4275ced0b
PMC3254124
22242037
10_1155_2012_595427
483720
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Germany
GeographicLocations_xml – name: Germany
GroupedDBID ---
29B
2WC
36B
4.4
53G
5GY
5VS
6PF
8R4
8R5
AAFWJ
AAWTL
ABDBF
ACUHS
ADBBV
ADJCN
ADRAZ
AFPKN
AHFXO
AJWEG
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AWYRJ
B0M
BAWUL
BCNDV
C1A
CAG
COF
CS3
DIK
DU5
E3Z
EAD
EAP
EBS
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
GROUPED_DOAJ
GX1
H13
HYE
IAO
IEA
IHR
IL9
INH
IPNFZ
ITC
KQ8
M48
O5R
O5S
OVT
P2P
PGMZT
Q2X
RHU
RIG
RNS
RPM
SV3
TR2
TUS
~8M
AAJEY
M~E
OK1
RHW
RHX
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c573t-c915235c87f22b709a4b95c78c90bef3c7a7703bf3d8f796e0166c5945c9c6e3
IEDL.DBID RHX
ISICitedReferencesCount 68
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000298816700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1740-2522
1740-2530
IngestDate Fri Oct 03 12:26:53 EDT 2025
Tue Sep 30 16:55:10 EDT 2025
Fri Sep 05 03:48:35 EDT 2025
Mon Jul 21 06:03:27 EDT 2025
Tue Nov 18 22:15:41 EST 2025
Sat Nov 29 03:28:49 EST 2025
Sun Jun 02 19:14:21 EDT 2024
Thu Sep 25 15:12:38 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 2012
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
http://creativecommons.org/licenses/by/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c573t-c915235c87f22b709a4b95c78c90bef3c7a7703bf3d8f796e0166c5945c9c6e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Academic Editor: Piotr Lewczuk
OpenAccessLink https://dx.doi.org/10.1155/2012/595427
PMID 22242037
PQID 916148122
PQPubID 23479
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_f8ea0814e91949f292cbd4f4275ced0b
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3254124
proquest_miscellaneous_916148122
pubmed_primary_22242037
crossref_primary_10_1155_2012_595427
crossref_citationtrail_10_1155_2012_595427
hindawi_primary_10_1155_2012_595427
emarefa_primary_483720
PublicationCentury 2000
PublicationDate 2012-01-01
PublicationDateYYYYMMDD 2012-01-01
PublicationDate_xml – month: 01
  year: 2012
  text: 2012-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Cairo, Egypt
PublicationPlace_xml – name: Cairo, Egypt
– name: Egypt
PublicationTitle Clinical & developmental immunology
PublicationTitleAlternate Clin Dev Immunol
PublicationYear 2012
Publisher Hindawi Puplishing Corporation
Hindawi Publishing Corporation
Wiley
Publisher_xml – name: Hindawi Puplishing Corporation
– name: Hindawi Publishing Corporation
– name: Wiley
References (35) 1997; 35
(41) 1995; 48
(37) 1995; 8
Centers for Disease Control and PreventionReported cases of Lyme disease by Year, United States, 1995–20092011[cited June 13, 2011]. http://www.cdc.gov/lyme/stats/chartstables/casesbyyear.html
(29) 2008; 51
(24) 2002; 114
(16) 1996; 25
(49) 1997; 127
(12) 1999; 282
(48) 2004; 2
(11) 2002; 114
(47) 1998; 279
(33) 1990; 150
(20) 2009; 1
(30) 1987; 155
(1) 2009; 75
(13) 2000; 142
(50) 2008; 51
(45) 2006; 12
Deutsche Gesellschaft für NeurologieDienerH.-C.PutzkiN.NeuroborrelioseLeitlinien für Diagnostik und Therapie in der Neurologie; 4 überarbeitete Auflage2008Stuttgart, GermanyGeorg Thieme Verlag654
(4) 2011; 17
(27) 2001; 29
(38) 2000; 118
(25) 2002; 40
Association of State and Territorial Public Health Laboratory DirectorsCenters for Disease Control and PreventionRecommendationsProceedings of the 2nd National Conference on Serologic Diagnosis of Lyme Disease1995Dearborn, Mich, USAAssociation of State and Territorial Public Health Laboratory Directors
(31) 1989; 262
LindgrenE.JaensonT. G.Lyme Borreliosis in Europe: Influences of Climate and Climate Change, Epidemiology, Ecology and Adaptation Measures2006Copenhagen, DenmarkWorld Health Organization
(34) 1992; 268
(6) 1998; 41
(5) 1993; 269
(32) 1990; 28
(46) 2003; 117
(10) 2001; 345
Kassenärztliche BundesvereinigungEinheitlicher Bewertungsmaßstab Version 2/20112011Berlin, GermanyKBV Kassenärztliche Bundesvereinigung
Statistisches BundesamtBevölkerungsstand2011[cited June 13, 2011]. http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/DE/Navigation/Statistiken/Bevoelkerung/Bevoelkerungsstand/Bevoelkerungsstand.psml
(8) 2008; 51
(22) 2009; 37
GibbsJ. N.Regulations and standards. ASRs: FDA issues final rule. IVD Technology1998[cited June 13, 2011]. http://www.ivdtechnology.com/article/asrs-fda-issues-final-rule
PlaceJ. F.The coming age of in vitro testing. IVD Technology2000[cited June 13, 2011]. http://www.ivdtechnology.com/article/coming-age-vitro-testing
ErhebungA. G.von SekundärdatenN.AG epidemiologische Methoden. Gute Praxis Sekundärdatenanalyse (GPS). Version 22008[cited June 13, 2011]. http://dgepi.de/pdf/infoboard/stellungnahme/gps-version2-final.pdf
(19) 2006; 44
(2) 1996; 156
(9) 2010; 12
(26) 2002; 291
(42) 1998; 287
(44) 1998; 20
(21) 1995; 44
Deutsche Dermatologische Gesellschaftkutane Manifestationen der Lyme Borreliose, [cited June 13, 2011]. http://www.awmf.org/uploads/tx_szleitlinien/013-044.pdf
(40) 1990; 150
(3) 2007; 357
22
44
46
25
47
48
27
29
50
(7) 2006
31
33
12
34
16
19
(15) 2008
1
2
3
4
5
6
8
(18) 2011
40
41
20
12422607 - Wien Klin Wochenschr. 2002 Jul 31;114(13-14):591-600
18985403 - Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1095-105
2327834 - Arch Intern Med. 1990 Apr;150(4):732-3
16597859 - J Clin Microbiol. 2006 Apr;44(4):1335-41
20132258 - Clin Microbiol Infect. 2011 Jan;17(1):69-79
19043762 - Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Nov;51(11):1329-39
7623762 - MMWR Morb Mortal Wkly Rep. 1995 Aug 11;44(31):590-1
11688905 - Infection. 2001 Oct;29(5):271-3
19542332 - Appl Environ Microbiol. 2009 Aug;75(16):5410-6
9485077 - Arthritis Rheum. 1998 Feb;41(2):195-204
8459513 - JAMA. 1993 Apr 14;269(14):1812-6
1640618 - JAMA. 1992 Aug 19;268(7):891-5
2685383 - JAMA. 1989 Dec 22-29;262(24):3431-4
9563198 - Zentralbl Bakteriol. 1998 Mar;287(3):241-7
16704815 - Emerg Infect Dis. 2006 Apr;12(4):653-60
7636514 - J Clin Epidemiol. 1995 Sep;48(9):1123-32
11450660 - N Engl J Med. 2001 Jul 12;345(2):115-25
7704889 - Clin Microbiol Rev. 1995 Jan;8(1):1-21
9041384 - J Clin Microbiol. 1997 Mar;35(3):537-43
12966749 - Public Health. 2003 Jul;117(4):264-73
9829450 - Clin Ther. 1998 Sep-Oct;20(5):993-1008; discussion 992
12089258 - J Clin Microbiol. 2002 Jul;40(7):2431-6
9438740 - JAMA. 1998 Jan 21;279(3):206-10
12422605 - Wien Klin Wochenschr. 2002 Jul 31;114(13-14):580-5
18273764 - Gesundheitswesen. 2008 Jan;70(1):54-60
8687256 - Arch Intern Med. 1996 Jul 22;156(14):1493-500
9412316 - Ann Intern Med. 1997 Dec 15;127(12):1109-23
3553353 - J Infect Dis. 1987 Jun;155(6):1325-7
10404913 - JAMA. 1999 Jul 7;282(1):62-6
10842472 - MMW Fortschr Med. 2000 Apr 13;142(15):28-31
2183731 - Arch Intern Med. 1990 Apr;150(4):761-3
12141751 - Int J Med Microbiol. 2002 Jun;291 Suppl 33:22-9
15335133 - Ann Fam Med. 2004 Jul-Aug;2(4):341-4
18985413 - Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1193-201
9119571 - Int J Epidemiol. 1996 Apr;25(2):435-42
17914043 - N Engl J Med. 2007 Oct 4;357(14):1422-30
19367101 - Curr Probl Dermatol. 2009;37:167-77
2203813 - J Clin Microbiol. 1990 Aug;28(8):1774-9
References_xml – volume: 156
  start-page: 1493
  issue: 14
  year: 1996
  end-page: 1500
  ident: 2
  article-title: The Lyme disease controversy: social and financial costs of misdiagnosis and mismanagement
– volume: 262
  start-page: 3431
  issue: 24
  year: 1989
  end-page: 3434
  ident: 31
  article-title: Antibody testing in Lyme disease. A comparison of results in four laboratories
– reference: ErhebungA. G.von SekundärdatenN.AG epidemiologische Methoden. Gute Praxis Sekundärdatenanalyse (GPS). Version 22008[cited June 13, 2011]. http://dgepi.de/pdf/infoboard/stellungnahme/gps-version2-final.pdf
– volume: 29
  start-page: 271
  issue: 5
  year: 2001
  end-page: 273
  ident: 27
  article-title: Incidence and prevalence of infection with human granulocytic ehrlichiosis agent in Germany. A prospective study in young healthy subjects
– volume: 269
  start-page: 1812
  issue: 14
  year: 1993
  end-page: 1816
  ident: 5
  article-title: The overdiagnosis of Lyme disease
– volume: 12
  start-page: 101
  year: 2010
  end-page: 110
  ident: 9
  article-title: Lyme-borreliose: Analyse der gemeldeten Erkrankungsfälle der Jahre 2007 bis 2009 aus den sechs östlichen Bundesländern
– volume: 37
  start-page: 167
  year: 2009
  end-page: 177
  ident: 22
  article-title: When is the best time to order a western blot and how should it be interpreted?
– volume: 2
  start-page: 341
  issue: 4
  year: 2004
  end-page: 344
  ident: 48
  article-title: Appropriateness of lyme disease serologic testing
– volume: 41
  start-page: 195
  issue: 2
  year: 1998
  end-page: 204
  ident: 6
  article-title: Pitfalls in the diagnosis and management of Lyme disease
– reference: Deutsche Dermatologische Gesellschaftkutane Manifestationen der Lyme Borreliose, [cited June 13, 2011]. http://www.awmf.org/uploads/tx_szleitlinien/013-044.pdf
– volume: 127
  start-page: 1109
  issue: 12
  year: 1997
  end-page: 1123
  ident: 49
  article-title: Laboratory evaluation in the diagnosis of Lyme disease
– volume: 357
  start-page: 1422
  issue: 14
  year: 2007
  end-page: 1430
  ident: 3
  article-title: A critical appraisal of “chronic lyme disease”
– volume: 1
  start-page: 1
  year: 2009
  end-page: 21
  ident: 20
  article-title: Zur Qualität der bakteriologischen Infektionsserologie in Deutschland: eine Metaanalyse der infektionsserologischen Ringversuche des Jahres 2006—Beitrag der Qualitätssicherungskommission der DGHM
– volume: 114
  start-page: 580
  issue: 13-14
  year: 2002
  end-page: 585
  ident: 24
  article-title: Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease
– volume: 155
  start-page: 1325
  issue: 6
  year: 1987
  end-page: 1327
  ident: 30
  article-title: An interlaboratory study of antibody to Borrelia burgdorferi
– volume: 51
  start-page: 1329
  issue: 11
  year: 2008
  end-page: 1339
  ident: 8
  article-title: Lyme-Borreliose: Forschungsbedarf und Forschungsansatze. Ergebnisse eines interdisziplinaren Expertentreffens am Robert Koch-Institut. [Lyme borreliosis: research gaps and research approaches. Results from an interdisciplinary expert meeting at the Robert Koch institute]
– volume: 291
  start-page: 22
  year: 2002
  end-page: 29
  ident: 26
  article-title: Foci of tick-borne diseases in Southwest Germany
– volume: 75
  start-page: 5410
  issue: 16
  year: 2009
  end-page: 5416
  ident: 1
  article-title: A new Borrelia species defined by multilocus sequence analysis of housekeeping genes
– reference: Kassenärztliche BundesvereinigungEinheitlicher Bewertungsmaßstab Version 2/20112011Berlin, GermanyKBV Kassenärztliche Bundesvereinigung
– reference: PlaceJ. F.The coming age of in vitro testing. IVD Technology2000[cited June 13, 2011]. http://www.ivdtechnology.com/article/coming-age-vitro-testing
– volume: 40
  start-page: 2431
  issue: 7
  year: 2002
  end-page: 2436
  ident: 25
  article-title: Seroprevalence of Babesia infections in humans exposed to ticks in midwestern Germany
– volume: 35
  start-page: 537
  issue: 3
  year: 1997
  end-page: 543
  ident: 35
  article-title: Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State laboratory of hygiene/college of American pathologists proficiency testing program
– volume: 44
  start-page: 590
  issue: 31
  year: 1995
  end-page: 591
  ident: 21
  article-title: Recommendations for test performance and interpretation from the second national conference on serologic diagnosis of Lyme disease
– reference: GibbsJ. N.Regulations and standards. ASRs: FDA issues final rule. IVD Technology1998[cited June 13, 2011]. http://www.ivdtechnology.com/article/asrs-fda-issues-final-rule
– reference: Statistisches BundesamtBevölkerungsstand2011[cited June 13, 2011]. http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/DE/Navigation/Statistiken/Bevoelkerung/Bevoelkerungsstand/Bevoelkerungsstand.psml
– volume: 150
  start-page: 732
  issue: 4
  year: 1990
  end-page: 733
  ident: 40
  article-title: Serologic tests for antibody to Borrelia burgdorferi. Another pandora's box for medicine?
– volume: 12
  start-page: 653
  issue: 4
  year: 2006
  end-page: 660
  ident: 45
  article-title: Economic impact of Lyme disease
– volume: 8
  start-page: 1
  issue: 1
  year: 1995
  end-page: 21
  ident: 37
  article-title: Laboratory diagnosis and interpretation of tests for syphilis
– volume: 51
  start-page: 1193
  issue: 10
  year: 2008
  end-page: 1201
  ident: 50
  article-title: Sekundardatenanalyse in der Versorgungsepidemiologie: Potenzial und Limitationen. [Secondary data analysis in the field of epidemiology of health care. Potential and limitations]
– reference: Centers for Disease Control and PreventionReported cases of Lyme disease by Year, United States, 1995–20092011[cited June 13, 2011]. http://www.cdc.gov/lyme/stats/chartstables/casesbyyear.html
– volume: 142
  start-page: 28
  issue: 15
  year: 2000
  end-page: 31
  ident: 13
  article-title: Diagnostik der Lyme-Borreliose. Wie Sie den Verdacht auf Borreliose erhärten. [Diagnosis of Lyme borreliosis. How to corroborate suspected borreliosis]
– reference: LindgrenE.JaensonT. G.Lyme Borreliosis in Europe: Influences of Climate and Climate Change, Epidemiology, Ecology and Adaptation Measures2006Copenhagen, DenmarkWorld Health Organization
– volume: 268
  start-page: 891
  issue: 7
  year: 1992
  end-page: 895
  ident: 34
  article-title: Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology
– volume: 20
  start-page: 993
  issue: 5
  year: 1998
  end-page: 1008
  ident: 44
  article-title: A cost-of-illness study of lyme disease in the United States
– volume: 51
  start-page: 1095
  issue: 10
  year: 2008
  end-page: 1105
  ident: 29
  article-title: Versorgungsforschung mit GKV-Routinedaten. Nutzungsmöglichkeiten versichertenbezogener Krankenkassendaten für Fragestellungen der Versorgungsforschung. [Health services research based on routine data generated by the SHI. Potential uses of health insurance fund data in health services research]
– volume: 44
  start-page: 1335
  issue: 4
  year: 2006
  end-page: 1341
  ident: 19
  article-title: Is serological testing a reliable tool in laboratory diagnosis of syphilis? Meta-analysis of eight external quality control surveys performed by the German infection serology proficiency testing program
– volume: 25
  start-page: 435
  issue: 2
  year: 1996
  end-page: 442
  ident: 16
  article-title: A framework for evaluation of secondary data sources for epidemiological research
– volume: 287
  start-page: 241
  issue: 3
  year: 1998
  end-page: 247
  ident: 42
  article-title: European interlaboratory comparison of Lyme borreliosis serology
– volume: 345
  start-page: 115
  issue: 2
  year: 2001
  end-page: 125
  ident: 10
  article-title: Lyme disease
– volume: 114
  start-page: 591
  issue: 13-14
  year: 2002
  end-page: 600
  ident: 11
  article-title: Quality of Lyme disease serology: lessons from the German proficiency testing program 1999–2001. A preliminary report
– volume: 282
  start-page: 62
  issue: 1
  year: 1999
  end-page: 66
  ident: 12
  article-title: Role of serology in the diagnosis of lyme disease
– volume: 150
  start-page: 761
  issue: 4
  year: 1990
  end-page: 763
  ident: 33
  article-title: Serologic tests for Lyme disease. Interlaboratory variability
– volume: 279
  start-page: 206
  issue: 3
  year: 1998
  end-page: 210
  ident: 47
  article-title: Tick bites and lyme disease in an endemic: setting problematic use of serologic testing and prophylactic antibiotic therapy
– reference: Association of State and Territorial Public Health Laboratory DirectorsCenters for Disease Control and PreventionRecommendationsProceedings of the 2nd National Conference on Serologic Diagnosis of Lyme Disease1995Dearborn, Mich, USAAssociation of State and Territorial Public Health Laboratory Directors
– volume: 48
  start-page: 1123
  issue: 9
  year: 1995
  end-page: 1132
  ident: 41
  article-title: Methodological issues in assessing reproducibility: a comparative study of various indices of reproducibility applied to repeat elisa serologic tests for Lyme disease
– volume: 117
  start-page: 264
  issue: 4
  year: 2003
  end-page: 273
  ident: 46
  article-title: Lyme disease—what is the cost for Scotland?
– volume: 17
  start-page: 69
  issue: 1
  year: 2011
  end-page: 79
  ident: 4
  article-title: Lyme borreliosis: clinical case definitions for diagnosis and management in Europe
– volume: 118
  year: 2000
  end-page: 12077
  ident: 38
  article-title: Bekanntmachung (AKZ 117-456000-02/2) zur EG-Richtlinie über in vitro Diagnostika (98/79/EG)
– reference: Deutsche Gesellschaft für NeurologieDienerH.-C.PutzkiN.NeuroborrelioseLeitlinien für Diagnostik und Therapie in der Neurologie; 4 überarbeitete Auflage2008Stuttgart, GermanyGeorg Thieme Verlag654
– volume: 28
  start-page: 1774
  issue: 8
  year: 1990
  end-page: 1779
  ident: 32
  article-title: Interlaboratory and intralaboratory comparisons of indirect immunofluorescence assays for serodiagnosis of Lyme disease
– ident: 2
  doi: 10.1001/archinte.156.14.1493
– volume: 118
  year: 2000
  ident: 38
  publication-title: Bundesgesetzbl
– ident: 4
  doi: 10.1111/j.1469-0691.2010.03175.x
– volume: 8
  start-page: 1
  issue: 1
  year: 1995
  ident: 37
  publication-title: Clinical Microbiology Reviews
  doi: 10.1128/CMR.8.1.1
– ident: 6
  doi: 10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y
– ident: 19
  doi: 10.1128/JCM.44.4.1335-1341.2006
– ident: 8
  doi: 10.1007/s00103-008-0703-6
– volume: 12
  start-page: 101
  year: 2010
  ident: 9
  publication-title: Epidemiol Bulletin
– volume: 345
  start-page: 115
  issue: 2
  year: 2001
  ident: 10
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJM200107123450207
– ident: 25
  doi: 10.1128/JCM.40.7.2431-2436.2002
– ident: 46
  doi: 10.1016/S0033-3506(03)00067-2
– volume: 127
  start-page: 1109
  issue: 12
  year: 1997
  ident: 49
  publication-title: Annals of Internal Medicine
  doi: 10.7326/0003-4819-127-12-199712150-00011
– ident: 40
  doi: 10.1001/archinte.150.4.732
– volume: 287
  start-page: 241
  issue: 3
  year: 1998
  ident: 42
  publication-title: Zentralblatt fur Bakteriologie
  doi: 10.1016/S0934-8840(98)80125-4
– ident: 12
  doi: 10.1001/jama.282.1.62
– ident: 20
  doi: 10.3205/lab000004
– ident: 27
  doi: 10.1007/s15010-001-2005-x
– ident: 47
  doi: 10.1001/jama.279.3.206
– ident: 5
  doi: 10.1001/jama.269.14.1812
– year: 2011
  ident: 18
– ident: 34
  doi: 10.1001/jama.268.7.891
– ident: 41
  doi: 10.1016/0895-4356(94)00243-J
– ident: 48
  doi: 10.1370/afm.117
– ident: 31
  doi: 10.1001/jama.262.24.3431
– volume: 28
  start-page: 1774
  issue: 8
  year: 1990
  ident: 32
  publication-title: Journal of Clinical Microbiology
  doi: 10.1128/JCM.28.8.1774-1779.1990
– volume: 35
  start-page: 537
  issue: 3
  year: 1997
  ident: 35
  publication-title: Journal of Clinical Microbiology
  doi: 10.1128/JCM.35.3.537-543.1997
– volume: 142
  start-page: 28
  issue: 15
  year: 2000
  ident: 13
  publication-title: MMW—Fortschritte der Medizin
– volume: 291
  start-page: 22
  year: 2002
  ident: 26
  publication-title: International Journal of Medical Microbiology
  doi: 10.1016/S1438-4221(02)80005-4
– volume: 155
  start-page: 1325
  issue: 6
  year: 1987
  ident: 30
  publication-title: Journal of Infectious Diseases
  doi: 10.1093/infdis/155.6.1325
– ident: 22
  doi: 10.1159/000213074
– year: 2006
  ident: 7
– volume: 114
  start-page: 580
  issue: 13-14
  year: 2002
  ident: 24
  publication-title: Wiener Klinische Wochenschrift
– ident: 44
  doi: 10.1016/S0149-2918(98)80081-7
– ident: 16
  doi: 10.1093/ije/25.2.435
– ident: 33
  doi: 10.1001/archinte.150.4.761
– ident: 50
  doi: 10.1007/s00103-008-0654-y
– ident: 1
  doi: 10.1128/AEM.00116-09
– volume: 114
  start-page: 591
  issue: 13-14
  year: 2002
  ident: 11
  publication-title: Wiener Klinische Wochenschrift
– start-page: 654
  volume-title: Neuroborreliose
  year: 2008
  ident: 15
– ident: 3
  doi: 10.1056/NEJMra072023
– volume: 44
  start-page: 590
  issue: 31
  year: 1995
  ident: 21
  publication-title: Morbidity and Mortality Weekly Report (MMWR)
– volume: 12
  start-page: 653
  issue: 4
  year: 2006
  ident: 45
  publication-title: Emerging Infectious Diseases
  doi: 10.3201/eid1204.050602
– ident: 29
  doi: 10.1007/s00103-008-0644-0
– reference: 12089258 - J Clin Microbiol. 2002 Jul;40(7):2431-6
– reference: 9119571 - Int J Epidemiol. 1996 Apr;25(2):435-42
– reference: 16704815 - Emerg Infect Dis. 2006 Apr;12(4):653-60
– reference: 10842472 - MMW Fortschr Med. 2000 Apr 13;142(15):28-31
– reference: 9412316 - Ann Intern Med. 1997 Dec 15;127(12):1109-23
– reference: 9563198 - Zentralbl Bakteriol. 1998 Mar;287(3):241-7
– reference: 7623762 - MMWR Morb Mortal Wkly Rep. 1995 Aug 11;44(31):590-1
– reference: 2203813 - J Clin Microbiol. 1990 Aug;28(8):1774-9
– reference: 9829450 - Clin Ther. 1998 Sep-Oct;20(5):993-1008; discussion 992
– reference: 7704889 - Clin Microbiol Rev. 1995 Jan;8(1):1-21
– reference: 18985403 - Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1095-105
– reference: 19043762 - Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Nov;51(11):1329-39
– reference: 12141751 - Int J Med Microbiol. 2002 Jun;291 Suppl 33:22-9
– reference: 10404913 - JAMA. 1999 Jul 7;282(1):62-6
– reference: 19542332 - Appl Environ Microbiol. 2009 Aug;75(16):5410-6
– reference: 8459513 - JAMA. 1993 Apr 14;269(14):1812-6
– reference: 9041384 - J Clin Microbiol. 1997 Mar;35(3):537-43
– reference: 2327834 - Arch Intern Med. 1990 Apr;150(4):732-3
– reference: 19367101 - Curr Probl Dermatol. 2009;37:167-77
– reference: 11450660 - N Engl J Med. 2001 Jul 12;345(2):115-25
– reference: 1640618 - JAMA. 1992 Aug 19;268(7):891-5
– reference: 8687256 - Arch Intern Med. 1996 Jul 22;156(14):1493-500
– reference: 11688905 - Infection. 2001 Oct;29(5):271-3
– reference: 7636514 - J Clin Epidemiol. 1995 Sep;48(9):1123-32
– reference: 16597859 - J Clin Microbiol. 2006 Apr;44(4):1335-41
– reference: 9485077 - Arthritis Rheum. 1998 Feb;41(2):195-204
– reference: 18273764 - Gesundheitswesen. 2008 Jan;70(1):54-60
– reference: 17914043 - N Engl J Med. 2007 Oct 4;357(14):1422-30
– reference: 2183731 - Arch Intern Med. 1990 Apr;150(4):761-3
– reference: 18985413 - Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1193-201
– reference: 12966749 - Public Health. 2003 Jul;117(4):264-73
– reference: 20132258 - Clin Microbiol Infect. 2011 Jan;17(1):69-79
– reference: 9438740 - JAMA. 1998 Jan 21;279(3):206-10
– reference: 3553353 - J Infect Dis. 1987 Jun;155(6):1325-7
– reference: 15335133 - Ann Fam Med. 2004 Jul-Aug;2(4):341-4
– reference: 12422607 - Wien Klin Wochenschr. 2002 Jul 31;114(13-14):591-600
– reference: 2685383 - JAMA. 1989 Dec 22-29;262(24):3431-4
– reference: 12422605 - Wien Klin Wochenschr. 2002 Jul 31;114(13-14):580-5
SSID ssj0025298
Score 1.7371551
Snippet Background. Data on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs...
Background . Data on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs...
Data on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs for...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
hindawi
emarefa
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1
SubjectTerms Borrelia - immunology
Clinical Laboratory Techniques - economics
Clinical Laboratory Techniques - standards
Germany - epidemiology
Health Care Costs
Humans
Incidence
Insurance, Health - economics
Lyme Disease - diagnosis
Lyme Disease - economics
Lyme Disease - epidemiology
Models, Statistical
Outpatients
Prevalence
Reagent Kits, Diagnostic - standards
Reproducibility of Results
Retrospective Studies
Sensitivity and Specificity
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQRSUuiFchvGSJnhBRHT_imFtbunCoKoRWqLfI8YNGKg7a3YLy7xnH3tUuquDCMY5jxZmJ5_uS8TcIHdbSWW0qAxboaAkIXJcN9zFHrKO2ssaJSez567m8uGguL9XnrVJfMScsyQOnB3fkG6chbHGngG4rTxU1neWeUymMs6SLqy-gnjWZylRL0KkKLsBtUsIBzTvzIHgC26_okVCCx0IyW7Fokuyf9uVqOIY4tX8VWfGv_jbs-WcK5VZMmj1A9zOYxMdpEg_RHRceof1UXnJ8jMazLOUdvuHZIuVMj-_wh5RdB9fgpKABbTpYfAptePD4fPzu8Ems2nHdD8t-iedRiQPG6AP-GBfyML7Hx_iLWy2G9UZNHGuqwZ1kiZMnaD47m59-KnOphdIIyValURDHmTCN9JR2kijNOyWMbIwinfPMSC1hbeg8s42XqnaAFGsjFBdGmdqxA7QXhuCeIUxqLW2kbYQzTrnXlje68gRgF5NMqgK9XT_z1mQZ8lgN47qd6IgQbTRQmwxUoMNN5x9JfeP2bifReJsuUTJ7agBHarMjtf9ypAIdZNNvxolq-5QU6E32hL_fA157SQtvaPztooMbbpYtAHDgnBWlBXqanGYzDoAzTgmDi-WOO-3MZPdM6K8mEXAGzB6w2fP_MfUX6F6cSfqy9BLtrRY37hW6a36u-uXi9fRm_QYoSiRu
  priority: 102
  providerName: Directory of Open Access Journals
Title Evaluating Frequency, Diagnostic Quality, and Cost of Lyme Borreliosis Testing in Germany : A Retrospective Model Analysis
URI https://search.emarefa.net/detail/BIM-483720
https://dx.doi.org/10.1155/2012/595427
https://www.ncbi.nlm.nih.gov/pubmed/22242037
https://www.proquest.com/docview/916148122
https://pubmed.ncbi.nlm.nih.gov/PMC3254124
https://doaj.org/article/f8ea0814e91949f292cbd4f4275ced0b
Volume 2012
WOSCitedRecordID wos000298816700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ (selected full-text)
  customDbUrl:
  eissn: 1740-2530
  dateEnd: 20161231
  omitProxy: false
  ssIdentifier: ssj0025298
  issn: 1740-2522
  databaseCode: DOA
  dateStart: 20030101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6xFZW4IF6F8FhZoidEROJHHHNrS5ceqgpVK7S3yHFsGqkkaLMF5d8zTrwRWyrE0Y5tOZlx5ht7_A3AYSZtpU1qUAIljRGB6zjnzseIlbRKK2PFQPb89VxeXOSrlfoSAmS7v4_w0dqhe57SD0IJTuUMZrnwunt5tprcKkGHjLcIrZMYCzTcwrvVdcfuDPT8wx1cjWW0SftX3gP-Vd-FM2-HS_5hfxaP4GEAjuRolPRjuGebJ7A_ppLsn0J_Gmi7m29ksR7jo_v35NMYSYd9yMiWgXW6qcgJ1pHWkfP-uyXHPkPHdd12dUeWnnUDx6gb8tn_tJv-Izkil3azbreXMonPn4YzCXQmz2C5OF2enMUhrUJshGSb2Ci02UyYXDpKS5kozUsljMyNSkrrmJFa4n-gdKzKnVSZRVSYGaG4MMpklh3AXtM29gWQJNOy8i5awhmn3OmK5zp1CUIsJplUEbzbfvPCBMpxn_niuhhcDyEKL6BiFFAEh1PjHyPTxt3Njr3wpiaeHnuoQJUpwmorXG41Yh1uVaq4clRRU1bcYXdhbJWUERwE0U_jeGZ9mkTwNmjCv-dAtlpS4Gr0Ryy6se1NVyDYRv8ypTSC56PSTOMgEOM0YdhZ7qjTzpvsPmnqq4Hwm6EXjzjs5X9N7hU88KVxm-g17G3WN_YN3Dc_N3W3nsNMrvL5sPMwH5bRb2txEqE
linkProvider Hindawi Publishing
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluating+Frequency%2C+Diagnostic+Quality%2C+and+Cost+of+Lyme+Borreliosis+Testing+in+Germany%3A+A+Retrospective+Model+Analysis&rft.jtitle=Clinical+%26+developmental+immunology&rft.au=M%C3%BCller%2C+I.&rft.au=Freitag%2C+M.+H.&rft.au=Poggensee%2C+G.&rft.au=Scharnetzky%2C+E.&rft.date=2012-01-01&rft.pub=Hindawi+Publishing+Corporation&rft.issn=1740-2522&rft.eissn=1740-2530&rft.volume=2012&rft_id=info:doi/10.1155%2F2012%2F595427&rft.externalDocID=10_1155_2012_595427
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1740-2522&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1740-2522&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1740-2522&client=summon